Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of potential effectiveness of a HPV vaccination programme for men.

The Joint Committee on Vaccination and Immunisation (JCVI), the expert committee that advises ministers on immunisation related issues, is currently considering the impact and cost-effectiveness of extending the human papillomavirus (HPV) vaccination programme to adolescent boys. This will include an assessment of the effectiveness of HPV vaccines in this group.

In November 2015, JCVI advised an HPV immunisation programme for men who have sex with men, up to and including the age of 45 years, who attend genitourinary medicine and HIV clinics. This was based on an assessment of the impact and cost-effectiveness of a three dose vaccination programme undertaken by Public Health England. Further information can be found here:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404831/pdf/ciw845.pdf